Zhao Yingze, Xiao Wenling, Wu Yanan, Fan Wenhui, Li Lei, Yue Can, Zhang Qingxu, Zhang Danni, Yuan Xiaoju, Yao Sijia, Liu Sai, Li Min, Wang Pengyan, Zhang Hangjie, Zhang Jie, Zhao Min, Zheng Xiaoqun, Liu Wenjun, Gao George F, Liu William J
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Research Units of Adaptive Evolution and Control of Emerging Viruses, Chinese Academy of Medical Sciences, Beijing, China.
J Immunol. 2023 Apr 15;210(8):1074-1085. doi: 10.4049/jimmunol.2200243.
Influenza A viruses (IAVs) and influenza B viruses (IBVs) cause annual epidemics in human populations with seasonal circulation spikes. Peptide AM58-66GL9 located at residues 58-66 of M1 protein of IAVs has been recognized as an immunodominant T cell epitope with HLA-A0201 restriction and broadly used as a positive reference in influenza immunity. This peptide also almost completely overlaps with a nuclear export signal (NES) 59-68 in IAV M1, which explains the limited escape mutations under the T cell immune pressure in this region. In this study, we investigated the potential immunogenicity and NES in the corresponding region of IBV. The long peptide covering this region can be recognized by specific T cells and induce robust expression of IFN-γ among HLA-B1501 donors in vivo, but not in HLA-A0201 donors. Among a series of truncated peptides derived from this region, we identified an immunodominant HLA-B1501-restricted T cell epitope BM58-66AF9 (ALIGASICF) in the M1 protein of IBV. Furthermore, the structure of the HLA-B1501/BM58-66AF9 complex shows that BM58-66AF9 performs a flat and featureless conformation that is similar to AM58-66GL9 presented by HLA-A0201. In contrast with IAV, the sequence around residues 55-70 of IBV M1 does not contain an NES. Our comparative study on IBVs and IAVs provides new insights into the immune and evolution characteristics of IBVs and may shed light on vaccine development for influenza viruses.
甲型流感病毒(IAV)和乙型流感病毒(IBV)每年都会在人群中引发季节性流行高峰的疫情。位于IAV M1蛋白58 - 66位残基的肽AM58 - 66GL9已被确认为具有HLA - A0201限制性的免疫显性T细胞表位,并广泛用作流感免疫的阳性对照。该肽也几乎与IAV M1中的核输出信号(NES)59 - 68完全重叠,这解释了该区域在T细胞免疫压力下逃逸突变有限的原因。在本研究中,我们调查了IBV相应区域的潜在免疫原性和NES。覆盖该区域的长肽可被特异性T细胞识别,并在体内诱导HLA - B1501供体中IFN - γ的强烈表达,但在HLA - A0201供体中则不然。在源自该区域的一系列截短肽中,我们在IBV的M1蛋白中鉴定出一个免疫显性的HLA - B1501限制性T细胞表位BM58 - 66AF9(ALIGASICF)。此外,HLA - B1501/BM58 - 66AF9复合物的结构表明,BM58 - 66AF9呈现出与HLA - A0201呈递的AM58 - 66GL9相似的扁平且无特征的构象。与IAV不同,IBV M1蛋白55 - 70位残基周围的序列不包含NES。我们对IBV和IAV的比较研究为IBV的免疫和进化特征提供了新的见解,并可能为流感病毒疫苗的开发提供思路。